about
Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirinAHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusionsAspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treThe Drug Derived Complexity Index (DDCI) Predicts Mortality, Unplanned Hospitalization and Hospital Readmissions at the Population Level
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giorgia De Berardis
@ast
Giorgia De Berardis
@en
Giorgia De Berardis
@es
Giorgia De Berardis
@nl
Giorgia De Berardis
@sl
type
label
Giorgia De Berardis
@ast
Giorgia De Berardis
@en
Giorgia De Berardis
@es
Giorgia De Berardis
@nl
Giorgia De Berardis
@sl
prefLabel
Giorgia De Berardis
@ast
Giorgia De Berardis
@en
Giorgia De Berardis
@es
Giorgia De Berardis
@nl
Giorgia De Berardis
@sl